Stephanie Daniel

Prior to joining Palo Alto Investors, Ms. Daniel held an analyst position for the Committee on Human Research (CHR) at the University of California, San Francisco (UCSF) facilitating the regulatory approval process of clinical research.
Ms. Daniel also worked as an analyst for UCSF Medical Center's Office of Finance working on Medicare reimbursement for organ transplant and graduate medical education.
Ms. Daniel holds a B.A.
in Psychology from the University of Virginia, is currently completing an M.A.
in Healthcare Ethics from Rush University and applying to medical school.